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Transferable quinolone resistance has not previously been reported in Argentina. Here we describe three
complex class 1 integrons harboring the novel allele qnrB10 in a unique region downstream of orf513, one of
them also containing aac(6)-Ib-cr within the variable region of integrons. The three arrays differed from
blaCTX-M-2-bearing integrons, which are broadly distributed in Argentina.
Three types of transferable (i.e., plasmid-encoded) quino-
lone resistance mechanisms have been reported so far, i.e., (i)
a quinolone-protective mechanism encoded by the qnr genes
(15), (ii) a double class antibiotic-modifying enzyme encoded
by a two-point mutation allele of aac(6)-Ib [named aac(6)-
Ib-cr] which acetylates ciprofloxacin and norfloxacin (14), and
(iii) an efflux pump encoded by the qepA gene (12, 19). Dif-
ferent transferable qnr determinants have been described so
far, i.e., qnrA, qnrB, and qnrS (15). The qnrB determinants
were associated with either the orf1005 gene, which encodes a
putative transposase (7), or the orf513 recombinase gene (5),
the latter included in a region recently named ISCR1 (16). The
origin of qnrB is unknown, although QnrB-like proteins were
recently found in members of the Vibrionaceae family (13).
Here we describe a novel quinolone resistance determinant,
qnrB10, downstream of orf513 and embedded within different
complex class 1 integrons.
(This study was presented in part at the 47th Interscience Con-
ference on Antimicrobial Agents and Chemotherapy, 17 to 20
September 2007, Chicago, IL [A. Petroni, P. Andres, A. Soler-
Bistue´, P. Quiroga, A. Zorreguieta, D. Centro´n, and M. Galas,
abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother., abstr.
C1-112, 2007].)
To investigate the occurrence of qnr genes in Argentina, we
focused on clinical isolates resistant to ciprofloxacin and to at
least two different families of antibiotics. Eighteen enterobac-
terial isolates from three hospitals from Buenos Aires were
analyzed for the presence of the qnrA, qnrB, and qnrS genes by
PCR (Table 1). None of them contained qnrA or qnrS, but
eight isolates were qnrB positive (Table 2). Sequence analysis
(NCBI BLAST V2.0) confirmed the identification of a novel
qnrB allele, designated qnrB10 (accession number DQ631414),
which showed maximal nucleotide identity (97%) with qnrB5
(6). The deduced QnrB10 protein (226 amino acids) has 98%
and 95% identity with QnrB5 and QnrB1, respectively. The
qnrB10 gene was cloned into the pCR2.1 vector (Invitrogen,
Carlsbad, CA) by following the manufacturer’s recommenda-
tions. The expression of this gene, under induction with 1 mM
isopropyl-1-thio--D-galactopyranoside (IPTG), increased the
ciprofloxacin MIC 32-fold compared to that for the host strain,
Escherichia coli DH10B (Table 3).
Two qnrB10-bearing isolates showing different resistance
profiles, Enterobacter cloacae E705 and Klebsiella pneumoniae
M7943, were selected for further studies. Relevant susceptibil-
ity data (4) are shown in Table 3. To gain insights into the
possible mechanisms of dissemination of qnrB10, we charac-
terized its genetic environments in both isolates. For this, we
used standard PCR long amplification conditions (fragments
4 kb) implemented with the Elongase kit (Invitrogen) in ac-
cordance with the manufacturer’s recommendations, followed
by DNA sequencing (Table 1; Fig. 1A). Each isolate harbored
a complex class 1 integron with a different variable region 1
(vr-1) composed of the 5 conserved sequence (5-CS) and the
3-CS but exhibiting another unique variable region, vr-2, lo-
cated between ISCR1 and the second copy of the 3-CS (Table
2; Fig. 1A). The E705 integron, named In131::ISCR1::qnrB10
(see below for a discussion of the nomenclature), showed a
new vr-1 comprising the aac(6)-IId and aadA1a cassettes,
while the In37::ISCR1::qnrB10 integron harbored aac(6)-Ib-cr,
blaOXA-30, catB3, and arr-3. This last array has been previously
found in In37 from an E. coli isolate from China, which has
qnrA1 in vr-2 (accession number AY259086) (18), and in the
integron from a K. pneumoniae strain isolated in France which
harbors qnrB4 in vr-2 [plasmid pRBDHA, accession number
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logı´a, Facultad de Medicina, Universidad de Buenos Aires, Paraguay
2155, P-12, Ciudad Auto´noma de Buenos Aires, Argentina. Phone: 54 11
5950-9500, ext. 2171. Fax: 54 11 4964 2554. E-mail: dcentron@gmail.com.
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TABLE 1. Primers used in PCR and DNA sequencing
Target and primera No.b Sequence (5–3) Reference
qnr genes
qnrA or -C (screening)
qnr-F TCAGCAAGAGGATTTCTCA This study
qnr-R GGCAGCACTATTACTCCCA
qnrS (screening)
qnrS-F ACGACATTCGTCAACTGCAA 6
qnrS-R TAAATTGGCACCCTGTAGGC
qnrB (screening)
qnrB-F 1 CCGACCTGAGCGGCACTGA This study
qnrB-R 2 CGCTCCATGAGCAACGATGCCT
qnrB10 (complete gene)c
qnrB-Met-F ATGTTGTCATTACTGTATA This study
qnrB-STOP-R CTAACCAATCACAGCGATG
Complex class 1 integrons
intI1
Inti1-R 3 TTCGAATGTCGTAACCGC 11
Inti1-F CGAGGCATAGACTGTAC
Sulpro3 (F) 4 GCCTGACGATGCGTGGA 8
vr-1
5CS (F) 5 GGCATCCAAGCAGCAAG 8
3CS (R) 6 AAGCAGACTTGACCTGA
orf513 (3-CS junction), orf513-R5 7 CGTAACCGTTTGTTTGAGTG This study
orf513 (screening)
orf513-F ATGGTTTCATGCGGGTT 2
orf513-R CTGAGGGTGTGAGCGAG 11
vr-2
orf513-F3 8 GTTCGATCCATCACAGAG This study
sul1-R 9 TTTGAAGGTTCGACAGC 1
orf5, orf5 lower (R) TGTCGACGTGGGTGAAT This study
orf6, In21-R 10 CGGTCGGACTGCAAGTGA This study
Resistance cassettes and other genes of the integrons
characterized in this study
aadA1
aadA1-F TTGCTGGCCGTACATTTG This study
aadA1-R TCATTGCGCTGCCATTC
aac(6)-Ib (any variant) and aac(6)-IId
aacF7334 11 CATCACAAAGTACAGCATCGTGACCAACAG This study
aacR7907 12 TTAGGCAACACTGCGTGTTCGCTCGAATGC
aac6IB (R) TGTGACGGAATCGTTGC 8
aacA4R (F) AAACACGCCAGGCATTC 1
blaOXA-30
oxaIII-F CATTATTTGAAGGAACTGAAG This study
oxaIII-R CACCAGTTTTCCCATACAGT
catB3
catout3-1 (F) 13 TTTCTGCTCTATCGGGAG This study
arr3out5-1 (R) TTGTTAGACGGCAAACTC
arr-3, sapC-sapB 14 GACTTGCTAACCACAGGG This study
arr-3, arr3-F
sapC1-R GAATGTGATTCAGTATCG This study
sapB4-F AACCCGTCGGCACAGGCCCG
arr-3, sapA
sapA-F 15 CAGTGGGTTCGTCTATTGC This study
sapA-R CGTTACTGTCCGTCGCC
arr-3, sapA-qnrB10 Junction
sapA3-R GCAGCAGCCTGACCACTC This study
qnrB-F3 CTTGGCATCGCTGTGATTG
a Only relevant primers (F, forward; R, reverse) are shown. Other sequence-based primers used in primer walking were excluded for brevity.
b Numbers correspond to primer locations in the PCR chart shown in Fig. 1A.
c Primers used for cloning qnrB10 in the pCR2.1 vector.
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AJ971343; aac(6)-Ib-cr had not been recognized at the time it
was published] (17). However, as shown in Fig. 1B, vr-1 of the
In37::ISCR1::qnrB10 integron differed from the other two
since it lacks a 101-bp duplication of the 3-CS located at the
5 end of the aac(6)-Ib-cr cassette. Also, the W3R mutation
in this gene presented a silent change (CGG3AGG) with
respect to the previously reported variant (14).
The genetic environments of qnrB10 in the two integrons
described here, (3)sapC-sapB-sapA and (5)pspF, mirrored
a conserved architecture found in all of the qnrB contexts
previously reported (accession numbers AM234698 and
AJ971343) that includes the location of qnrB alleles in an
orientation opposite to that of orf513 (Fig. 1A) (3, 5, 17). The
sap operon encodes a putative peptide transport system in
gram-negative bacteria, while the pspF gene is a transcriptional
activator of the stress-inducible psp operon. However, a deeper
analysis of the qnrB2, qnrB4, and qnrB10 environments showed
relevant differences. The sap and psp operons were truncated
at different outer points, and the intergenic regions between
sapA and the qnrB alleles were different (Fig. 1A). Moreover,
analysis of the inner boundary of the second 3-CS showed
deletions of different lengths in this element when comparing
the complex class 1 integrons described so far (Fig. 1C). These
data suggest that the qnrB alleles are located in similar genetic
contexts from probably different genomic sources, as has been
described previously for blaCTX-M-2 alleles (1, 16).
To our knowledge, there is no real consensus on the naming
of complex class 1 integrons. Therefore, we tried to follow the
simplest criterion. We show here three class 1 integrons with
essentially the same vr-1 [aac(6)-Ib-cr, blaOXA-30, catB3, and
arr-3] but different vr-2s. Since these three harbored the same
array of cassettes with alleles that are supposed to confer the
same antimicrobial resistance profile, we named the integron
from K. pneumoniae M7943 In37, focusing on vr-1. In order to
specify the genetic platform of the complex class 1 integrons,
we added the genetic specification of vr-2, resulting
In37::ISCR1::qnrA1 and In37::ISCR1::qnrB4-blaDHA-1 for the
integrons described by Wang et al. (18) and Verdet et al. (17),
respectively, and In37::ISCR1::qnrB10 for our finding in K.
pneumoniae M7943.
Transfer of In131::ISCR1::qnrB10 and In37::ISCR1::qnrB10
was assayed by biparental conjugation as described before (10),
with E. coli J53-AzR (azide resistant) as the recipient strain.
Transconjugants were selected on Mueller-Hinton agar sup-
plemented with sodium azide (100 g/ml) and ampicillin (100
g/ml), sulfamethoxazole (100 g/ml), or kanamycin (50 g/
ml). Only In37::ISCR1::qnrB10 was detected in a transconju-
gant, named M7943-TC2, that had the quinolone and amino-
TABLE 2. Relevant characteristics of clinical isolates and transconjugants used in this study
Isolate or strain Yr ofisolation Hospital Relevant resistance phenotype
a qnrB10b vr-1 of qnrB10-bearingintegrons
C. freundii CF701 2005 H2 AMP-AMC-CAZ-FEP-TZP-AMK-GEN-CHL-TET-
SXT-NAL-CIP
 aac(6)-IId-aadA1a
C. freundii CF702 2005 H3 AMP-AMC-CAZ-FEP-TZP-MEM-CHL-SXT-NAL-CIP  aac(6)-Ib-aadA1a
E. aerogenes E704 2005 H3 AMP-AMC-CAZ-TZP-GEN-CHL-SXT-NAL-CIP  aac(6)-IId-aadA1a
E. cloacae E701 2005 H3 AMP-AMC-CAZ-TZP-SFI-NAL-CIP  aac(6)-Ib-aadA1a
E. cloacae E702 2005 H2 AMP-AMC-CAZ-FEP-TZP-AMK-GEN-CHL-TET-
SXT-NAL-CIP
 aac(6)-IId-aadA1a
E. cloacae E703 2005 H2 AMP-AMC-CAZ-FEP-TZP-GEN-CHL-SXT-NAL-CIP  aac(6)-IId-aadA1a
E. cloacae E705 2005 H2 AMP-AMC-CAZ-TZP-GEN-CHL-TET-SXT-NAL-CIP  aac(6)-IId-aadA1a
K. pneumoniae
M7943
2006 H1 AMP-AMC-CTX-CAZ-FEP-TZP-AMK-GEN-CHL-
TET-SXT-NAL-CIP
 aac(6)-Ib-cr-blaOXA-30-
catB3-arr-3
E. coli M7943-TC2 AMP-AMC-FEP-TZP-AMK-CHL-SFI-NAL-CIP  aac(6)-Ib-cr-blaOXA-30-
catB3-arr-3
a Antimicrobial resistance and reduced susceptibility were tested by the disk diffusion method (4). Abbreviations: AMC, amoxicillin-clavulanic acid; AMK, amikacin;
AMP, ampicillin; CAZ, ceftazidime; CHL, chloramphenicol; CIP, ciprofloxacin; CTX, cefotaxime; FEP, cefepime; GEN, gentamicin; MEM, meropenem; NAL,
nalidixic acid; SFI, sulfisoxazole; SXT; trimethoprim-sulfamethoxazole; TET, tetracycline; TZP, piperacillin-tazobactam.
b The presence of qnrB10 was tested by PCR and sequence analysis (Table 1).
TABLE 3. Susceptibility profiles of relevant clinical isolates, bacterial recipient for conjugation experiments, transconjugants, clones,
and strains used in this study
Strain
MIC (g/ml)a
NAL CIP NOR LVX OFX GAT MXF KAN TOB AMK
E. cloacae E705 256 64 64 64 64 32 64 256 32 8
K. pneumoniae M7943 128 32 32 4 8 4 8 128 16 16
E. coli M7943-TC2 16 2 2 0.5 0.5 0.5 1 64 16 4
E. coli J53-AzR 4 0.015 0.03 0.03 0.06 0.03 0.06 2 0.25 0.5
E. coli DH10B/pCRQB10b 8 0.125 0.125 0.06 0.06 0.06 0.125 256 0.25 2
E. coli DH10B/pCR2.1 2 0.004 0.008 0.004 0.004 0.004 0.004 256 0.25 2
E. coli DH10B 2 0.004 0.008 0.004 0.004 0.004 0.004 1 0.25 1
a MICs (4) were analyzed under induction by 1 mM IPTG. The antibiotics used for MIC determination were as follows: NAL, nalidixic acid; CIP, ciprofloxacin; NOR,
norfloxacin; LVX, levofloxacin; OFX, ofloxacin; GAT, gatifloxacin; MXF, moxifloxacin; KAN, kanamycin; TOB, tobramycin; AMK, amikacin.
b The complete qnrB10 gene was cloned into pCR2.1 in the sense orientation with respect to the lac promoter.
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FIG. 1. Genetic organization of qnrB10-containing complex class 1 integrons. (A) Genes are represented by arrowed boxes (qnr genes are in
black), attC is represented by vertical ovals, and the putative origin of replication of ISCR1 (16) is represented by a black diamond. The 3-CS and
the second copy of this element (3-CS2) are shown by white arrowed boxes. The hatched horizontal bar indicates the sequenced regions (13,281
bp in In37::ISCR1::qnrB10 and 10,762 bp in In131::ISCR1::qnrB10). Thick horizontal lines indicate the principal amplicons obtained by PCR
cartography of the qnrB10-bearing integrons (numbers indicate the corresponding primers in Table 1). The integrons In37::ISCR1::qnrA1 (18) and
In37::ISCR1::qnrB4-blaDHA-1 (17), having essentially the same vr-1 as In37::ISCR1::qnrB10, were included for comparison (sequences were
truncated at the two vertical thin lines). Shaded areas with percentages depict identities (id.) between vr-2s. The X, Y, and Z boxes indicate regions
of no homology with GenBank sequences. (B) Comparison of the aac(6)-Ib-cr cassettes of In37::ISCR1::qnrA1 and In37::ISCR1::qnrB10
(nucleotides 1492 to 2261 and 1040 to 1702 in the sequences with accession numbers AY259086 and EF636461, respectively). Sequences are
numbered from the first nucleotide following the junction with the 5-CS, and dashes represent gaps introduced to maximize alignment (ClustalX
software, available at ftp://ftp-igbmc.u-strasbg.fr/pub/). Identical nucleotides in the two sequences are in bold. The 101-bp duplication of the 3-CS
is underlined. The start (boxed) and stop (*) codons of each aac(6)Ib-cr gene are indicated, and the amino acid sequence of the deduced protein
is shown below each nucleotide sequence (14). For brevity, other regions showing 100% nucleotide (or amino acid) identity are represented by dots.
The silent CGG-to-AGG change (see the text for details) is also shown. (C) Deletions at the inner boundary of 3-CS2. Nucleotide sequences
correspond to In0 (normal 3-CS, M73819), In131::ISCR1::qnrB10 (EU052800), In37::ISCR1::qnrB10 (EF636461), In35::ISCR1::blaCTX-M-2
(AY079169), In7::ISCR1::dfrA10 (L06418), In37::ISCR1::qnrA1 (AY259086), and In6::ISCR1::cat2 (U04277). The deletion endpoint in 3-CS2 is
defined by the first base appearing in bold. Base 1 of In0 corresponds to the nucleotide at position 65 from the normal 3-CS.
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glycoside resistance profiles for aac(6)-Ib-cr and qnrB10 genes
(Table 2). The presence of In37::ISCR1::qnrB10 was also con-
firmed by PCR cartography.
The other six qnrB10-producing isolates studied here
showed the same vr-2 rearrangement and either vr-1 of
In131::ISCR1::qnrB10 or a different one composed of the
aac(6)-Ib and aadA1a cassettes (Table 2; Fig. 1A), which was
named In132. None of the qnrB10-bearing integrons studied
here showed the In35 rearrangement [aac(6)-Ib-blaOXA-2-orfD],
which is the most widespread complex class 1 integron involved
in the dispersion of blaCTX-M-2 in the bacterial population from
Argentina (2).
Recently, Toleman et al. proposed that ISCR1 is involved in
the spread of class 1 integrons through a mechanism that
mobilizes adjacent DNA sequences (16). This is in agreement
with the finding that cassettes are more often transferred as
part of the entire integron structure than as individual gene
cassettes (9). The finding of In37 derivatives from different
geographical regions with diverse vr-2s is consistent with the
speculations of Toleman et al. On the basis of this hypothesis,
we would also expect to find In35 associated with qnrB10 in our
nosocomial isolates.
In conclusion, the particular epidemiology of complex class
1 integrons found in isolates harboring a novel qnrB allele, as
well as the emergence of aac(6)-Ib-cr cassettes in our bacterial
population, evidences the need for national surveillance in
order to estimate the prevalence of these mechanisms.
Nucleotide sequence accession numbers. The nucleotide se-
quences determined in this work have been submitted to the
GenBank database and assigned accession no. DQ631414,
EF636461, EU052800, and EU091084.
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